The FDA has sent the Draft Guidance for Homeopathic Medicines to the White House:
- The Draft Guidance defines the regulatory framework for homeopathic medicines
- We have concerns about this Draft Guidance – many of you signed the petition sharing those concerns with the FDA in the past. See details here.
- We believe that the Draft Guidance in its current form will limit access to homeopathic remedies going forward.
We now have a unique opportunity to communicate with the President and his advisors because the FDA has submitted its Draft Guidance to the Office of Information and Regulatory Affairs (OIRA) which operates by law within the Executive Office of the President.
OIRA reviews significant regulatory changes to make sure
1) that they are consistent with the law,
2) that there has been a proper analysis of both costs and benefits,
3) that the FDA has made a "reasoned determination that the
benefits justify the costs."
We are asking you to send a message today to prevent this Draft Guidance from being implemented. A clear message has been drafted which explains the issue and desired outcome. It is quick and easy to send to the president, regulators and legislators.
